Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

New data on Crohn’s disease presented at Digestive Disease Week in Chicago.

Posted Jul 01 2009 6:46pm

New studies show that patients with moderate to severe Crohn’s disease can maintain remission through three years of therapy with adalimumab (HUMIRA®).  It appears that not only has adalimumab demonstrated its efficacy at the beginning of the treatment but it has also shown to maintain its effectiveness over the long-term – pretty important when considering how to manage a chronic condition like Crohn’s disease.

A secondary analysis of the same study demonstrated that patients being treated with adalimumab for Crohn’s disease may also be able to achieve long-term steroid-free remission.

  • Share/Save/Bookmark

Related posts

Tags: adalimumab, crohns disease

Post a comment
Write a comment:

Related Searches